Future Medicine Co., Ltd. (XKON:341170)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,500.00
+100.00 (7.14%)
At close: Mar 5, 2026
Market Cap15.61B +29.7%
Revenue (ttm)1.00B
Net Income-13.37B
EPS-1,637.42
Shares Out9.28M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume31,159
Average Volume17,030
Open1,500.00
Previous Close1,400.00
Day's Range1,400.00 - 1,600.00
52-Week Range680.00 - 3,300.00
Beta-0.12
RSI50.73
Earnings Daten/a

About Future Medicine

Future Medicine Co., Ltd. operates as a drug development company worldwide. It develops therapeutic drugs for non-alcoholic liver disease treatment and the anticancer field. The company was founded in 2015 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 2015
Employees 26
Stock Exchange Korea New Exchange
Ticker Symbol 341170
Full Company Profile

Financial Performance

Financial Statements